{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:32:05Z","timestamp":1791304325621,"version":"4.3.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.ajg.2011.03.001","type":"journal-article","created":{"date-parts":[[2011,5,6]],"date-time":"2011-05-06T16:52:01Z","timestamp":1304700721000},"page":"109-111","source":"Crossref","is-referenced-by-count":17,"title":["Vitiligo in a patient receiving infliximab for refractory ulcerative colitis"],"prefix":"10.1016","volume":"12","author":[{"given":"Waleed A.","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Al-Enzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqer A.","family":"Alsurayei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali E.","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"978","key":"10.1016\/j.ajg.2011.03.001_b0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad Med J"},{"issue":"23","key":"10.1016\/j.ajg.2011.03.001_b0010","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1572-0241.2003.07161.x","article-title":"Safety and steroid-sparing experience using infliximab for Crohn\u2019s disease at a pediatric inflammatory bowel disease center","volume":"98","author":"Stephens","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.ajg.2011.03.001_b0020","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000069965","article-title":"Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy","volume":"206","author":"Devos","year":"2003","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0025","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1046\/j.1365-2133.2003.05384.x","article-title":"CD30+ T-cell lymphoma in a patient with psoriasis treated with ciclosporin and infliximab","volume":"149","author":"Mahe","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0030","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","article-title":"Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn\u2019s disease: a prospective cohort study","volume":"125","author":"Vermeire","year":"2003","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1053\/j.gastro.2003.10.047","article-title":"The safety profile of infliximab in patients with Crohn\u2019s disease: the Mayo clinic experience in 500 patients","volume":"126","author":"Colombel","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ajg.2011.03.001_b0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000111523","article-title":"Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab","volume":"216","author":"Fabre","year":"2008","journal-title":"Dermatology"},{"issue":"8","key":"10.1016\/j.ajg.2011.03.001_b0045","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1001\/archderm.140.8.1012-a","article-title":"Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicles","volume":"140","author":"Ettefagh","year":"2004","journal-title":"Arch Dermatol"},{"issue":"9","key":"10.1016\/j.ajg.2011.03.001_b0050","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1468-3083.2007.02165.x","article-title":"Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab","volume":"21","author":"Vestergaard","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.ajg.2011.03.001_b0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2133.2006.07665.x","article-title":"Infliximab-induced acne: report of two cases","volume":"156","author":"Bassi","year":"2007","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ajg.2011.03.001_b0060","first-page":"1955","article-title":"Leukocytoclastic vasculitis associated with tumor necrosis factor-\u03b1 blocking agents","volume":"31","author":"Mohan","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ajg.2011.03.001_b0065","unstructured":"United States Food and Drug Administration. Tumor necrosis factor alpha (TNF-a) antagonists [infliximab (marketed as REMICADE), etanercept (marketed as ENBREL) and adalimumab (marketed as HUMIRA)]: Serious skin reactions. FDA Drug Safety Newsl 2008;1:18\u201322."},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000081494","article-title":"Infliximab-induced vitiligo","volume":"210","author":"Ramirez Hernandez","year":"2005","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.ajg.2011.03.001_b0075","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.mehy.2008.12.033","article-title":"Use of anti-tumor necrosis factor agents: a possible therapy for vitiligo","volume":"72","author":"Lv","year":"2009","journal-title":"Med Hypotheses"},{"issue":"959","key":"10.1016\/j.ajg.2011.03.001_b0080","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","article-title":"Important cutaneous manifestations of inflammatory bowel disease","volume":"81","author":"Trost","year":"2005","journal-title":"Postgrad Med J"},{"issue":"10","key":"10.1016\/j.ajg.2011.03.001_b0085","first-page":"1010","article-title":"Alopecia areata, vitiligo, scleroderma and ulcerative colitis","volume":"67","author":"Thompson","year":"1974","journal-title":"Proc R Soc Med"},{"issue":"269","key":"10.1016\/j.ajg.2011.03.001_b0090","first-page":"835","article-title":"The association of autoimmune disorders with inflammatory bowel disease","volume":"72","author":"Snook","year":"1989","journal-title":"Q J Med"},{"issue":"1","key":"10.1016\/j.ajg.2011.03.001_b0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00005176-199407000-00003","article-title":"Extraintestinal manifestations of inflammatory bowel disease in children","volume":"19","author":"Hyams","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197911000335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197911000335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T15:24:17Z","timestamp":1712417057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197911000335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1687197911000335"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2011.03.001","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}